Phio Pharmaceuticals Corp. (PHIO) Form 8-K — Sep 28, 2026
$PHIOForm 8-KItems 5.02, 5.07, 9.01Filed Sep 28, 2026, 4:01 PM ET0001437749-26-031337Original filing
Phio Pharmaceuticals stockholders approved an amendment to the 2020 Long Term Incentive Plan at the September 28, 2026 annual meeting, increasing shares available for issuance by 1,500,000 to a total of 2,452,017 shares. The vote was relatively tight for the plan amendment, with 1,155,945 shares for versus 194,070 against and 34,468 abstaining, out of 5,207,580 shares present at the meeting. Shareholders also elected all six directors and ratified Grant Thornton as auditor for fiscal 2026.
Key figures
- Plan share increase
- 1500000
- Proposal3 votes for
- 1155945
- Proposal3 votes against
- 194070
- Shares present at meeting
- 5207580
- Total plan shares available
- 2452017
- Shares outstanding record date
- 11617250
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.